CD8A and neoplasm: During priming, CD4+ and CD8+ T cells can be polarized to distinct subpopulations of effector cells, such as EM CD8+ T cells, also commonly known as cytotoxic T lymphocytes [10] capable of counteracting or terminating tumor progression.